Drug Safety
FDA reports cases of allergic contact dermatitis from topical doxepin
Published in Medical Letter on the CDC and FDA, April 13th, 2003
According to a study from the United States, "A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration."
"Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days," said Renan A. Bonnel and collaborators at the Food and Drug Administration. "Allergic contact dermatitis to doxepin cream should be considered in patients whose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anemia Therapy
Iron plus sulfadoxine-pyrimethamine best for anemia in children with malaria - Rabies
High viral infectivity is likely reason for rabies deaths from uncommon bats - AIDS Therapy
FDA approves first drug in new class - Influenza Vaccine
Vaccine containing outer-surface protein A protects against Lyme disease - Tuberculosis
First revised guidelines issued since 1994 - AIDS Therapy
FDA grants accelerated approval to Fuzeon - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
